TH147124A - Long-acting insulin formulation - Google Patents
Long-acting insulin formulationInfo
- Publication number
- TH147124A TH147124A TH1201005994A TH1201005994A TH147124A TH 147124 A TH147124 A TH 147124A TH 1201005994 A TH1201005994 A TH 1201005994A TH 1201005994 A TH1201005994 A TH 1201005994A TH 147124 A TH147124 A TH 147124A
- Authority
- TH
- Thailand
- Prior art keywords
- insulin
- long
- acting insulin
- insulin formulation
- concentration
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title claims abstract 3
- 239000000203 mixture Substances 0.000 title claims abstract 3
- 102000016261 Long-Acting Insulin Human genes 0.000 title 1
- 108010092217 Long-Acting Insulin Proteins 0.000 title 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims abstract 11
- 102000004877 Insulin Human genes 0.000 claims abstract 6
- 108090001061 Insulin Proteins 0.000 claims abstract 6
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract 2
- 230000004313 glare Effects 0.000 claims 1
- -1 hydroxyl insulin Chemical compound 0.000 abstract 1
Abstract
DC60 (16/11/55) คำขอนี้เกี่ยวข้องกับสูตรผสมทางเภสัชกรรมแบบแอคเควียสซึ่งประกอบรวมด้วย 200 - 1000 U/mL [โมลาร์เท่ากับ 200 - 1000 IU ของอินซูลินของคน] ของอินซูลินกลาร์จีน โดยมีเงื่อนไขว่า ความเข้มข้นของสูตรผสมดังกล่าวไม่ใช่ 684 U/mL ของอินซูลินกลาร์จีน, และการใช้ของมัน สิทธิบัตรยา DC60 (16/11/55) This request relates to an active pharmaceutical formulation consisting of 200 - 1000 U / mL [molar equivalent to 200 - 1000 IU of human insulin] of hydroxyl insulin. Chinese Provided that The concentration of the above formulation was not 684 U / mL of Gene insulin, and its use, the drug patent.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH147124A true TH147124A (en) | 2016-03-04 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019500517A1 (en) | Long-acting formulations of insulins | |
| UA117103C2 (en) | Glucagon analogues | |
| PH12014502778B1 (en) | Antibody formulation | |
| BR112016016290A2 (en) | PHARMACEUTICAL COMPOSITIONS OF FAST-ACTING INSULIN, INFUSION SET, INFUSION SET SYSTEM AND USES OF MONOMER OR DIMERIC INSULIN ANALOGS | |
| AR090491A1 (en) | TREATMENT OF MULTIPLE SCLEROSIS WITH A COMBINATION OF LAQUINIMOD AND DIMETILO FUMARATE | |
| RS52367B (en) | Reduced volume formulation of glatiramer acetate and methods of administration | |
| UA111415C2 (en) | Pharmaceutical preparation containing dihydroquinazoline derivative possessing antiviral activity | |
| WO2014066915A3 (en) | Methods and compositions to produce ss-rnai activity with enhanced potency | |
| PH12015501931A1 (en) | Treatment of diabetes mellitus by long-acting formulations of insulins | |
| MX369742B (en) | Modified release formulation. | |
| UA109544C2 (en) | PHARMACEUTICAL COMPOSITION CONTAINING PARACETAMOL AND METHOD OF MANUFACTURING | |
| RU2012110454A (en) | METHOD FOR PRODUCING MICROCapsules OF MEDICINES OF THE CEPHALOSPORIN GROUP IN INTERFERON | |
| TH147124A (en) | Long-acting insulin formulation | |
| WO2012020219A3 (en) | Formulations for infusion of type b lantibiotics | |
| MX2011011879A (en) | Use of betaxanthins and derivatives thereof for the preparation of a drug for the treatment of prediabetes and diabetes. | |
| BR112017012975A2 (en) | injectable paracetamol formulations | |
| WO2013127539A3 (en) | Pharmaceutical formulation containing flupirtin | |
| UA110935C2 (en) | Sustained-release insulin formulation | |
| UA111785C2 (en) | A COMPOSITION FOR THE TREATMENT OF Warts And A WAY OF TREATMENT | |
| TH172399A (en) | Treatment of diabetes with long-acting insulin formulations | |
| MX2011011880A (en) | Use of derivatives of betanidine and isobetanidine for the preparation of a drug for the treatment of prediabetes and diabetes. | |
| MX2011011881A (en) | Use of delphinidin and the derivatives thereof to prepare a drug for treating prediabetes and diabetes. | |
| TH1501000643A (en) | Treatment of immune and inflammatory disease | |
| TH178094A (en) | ||
| TH180780A (en) | Iris dilatation solution And stable anti-inflammatory That is free from preservatives for injection |